Literature DB >> 30481997

Levels of circulating microparticles in septic shock and sepsis-related complications: a case-control study.

Annalisa Boscolo1, Elena Campello2, Diana Bertini1, Luca Spiezia2, Vittorio Lucchetta1, Eleonora Piasentini1, Claudia M Radu2, Leonardo Manesso1, Carlo Ori1, Paolo Simioni3.   

Abstract

BACKGROUND: Microparticles (MP) have been largely studied as potential biomarkers in septic shock (SS) though their biological and clinical relevance is still unclear. This case-control study describes the trend of various MP subtypes during SS to evaluate their possible association with severity of illness and sepsis-related complications (disseminated intravascular coagulation [DIC] and acute kidney injury [AKI]).
METHODS: Forty patients admitted to the Intensive Care Unit with SS and 40 matched healthy volunteers were recruited. AnnexinV+, E-selectin+, thrombomodulin (TM+), leukocyte-derived (CD45+, CD36+) and platelet-derived MP (PMP-expressed as PMP/platelets ratio) were measured by flow-cytometry at baseline, on day 1, 3 and 7 after diagnosis. Severity of illness was assessed by Sequential Organ Failure Assessment Score, duration of vasoactive support and mechanical ventilation. Sepsis-related complications were considered.
RESULTS: Overall, septic patients showed higher levels of all MP considered compared to controls. TM+MP were significantly lower in more severe sepsis, while CD36+MP and PMP/platelets ratio were significantly increased in patients requiring longer vasoactive support and mechanical ventilation. As for sepsis-related complications, a higher PMP/platelets ratio in patients who developed DIC and increased E-selectin+MP in subjects who developed AKI were observed. PMP/platelets ratio at baseline was significantly associated with longer vasoactive support (OR=1.59 [1.05-2.42]), longer mechanical ventilation (OR=1.6 [1.06-2.42]) and DIC occurrence (OR=1.45 [1.08-1.96]).
CONCLUSIONS: A global response through extra-vesiculation of endothelial cells, leukocytes and platelets during the early stages of SS was confirmed. The cellular activation was detected until day 3 after diagnosis. PMP/platelets ratio at diagnosis may be useful to evaluate SS severity and DIC occurrence.

Entities:  

Mesh:

Year:  2018        PMID: 30481997     DOI: 10.23736/S0375-9393.18.12782-9

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  9 in total

Review 1.  Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures.

Authors:  Mallorie Boron; Tiffany Hauzer-Martin; Joseph Keil; Xue-Long Sun
Journal:  TH Open       Date:  2022-07-11

Review 2.  Blood Cell-Derived Microvesicles in Hematological Diseases and beyond.

Authors:  Hara T Georgatzakou; Sotirios P Fortis; Effie G Papageorgiou; Marianna H Antonelou; Anastasios G Kriebardis
Journal:  Biomolecules       Date:  2022-06-08

3.  Preliminary study of microparticle coagulation properties in septic patients with disseminated intravascular coagulation.

Authors:  Shishuai Meng; Kai Kang; Dongsheng Fei; Songlin Yang; Quankuan Gu; ShangHa Pan; Mingyan Zhao
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

4.  Therapeutic Potential of Extracellular Vesicles for Sepsis Treatment.

Authors:  Stephanie M Kronstadt; Alex E Pottash; Daniel Levy; Sheng Wang; Wei Chao; Steven M Jay
Journal:  Adv Ther (Weinh)       Date:  2021-04-29

5.  Circulating Neutrophil-Derived Microparticles Associated with the Prognosis of Patients with Sepsis.

Authors:  Hong-Peng Chen; Xiao-Yan Wang; Xiao-Yan Pan; Wang-Wang Hu; Shu-Ting Cai; Kiran Joshi; Lie-Hua Deng; Daqing Ma
Journal:  J Inflamm Res       Date:  2020-12-14

Review 6.  The Role of Platelet-Derived Extracellular Vesicles in Immune-Mediated Thrombosis.

Authors:  Alicia S Eustes; Sanjana Dayal
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

7.  Whole-blood hypocoagulable profile correlates with a greater risk of death within 28 days in patients with severe sepsis.

Authors:  Annalisa Boscolo; Luca Spiezia; Elena Campello; Diana Bertini; Vittorio Lucchetta; Eleonora Piasentini; Alessandro De Cassai; Paolo Simioni
Journal:  Korean J Anesthesiol       Date:  2020-01-07

8.  Research Advances in the Subtype of Sepsis-Associated Thrombocytopenia.

Authors:  Xinghui Wu; Yue Li; Huasheng Tong
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

9.  Unfractionated heparin improves the clinical efficacy in adult sepsis patients: a systematic review and meta-analysis.

Authors:  Sifeng Fu; Sihan Yu; Liang Wang; Xiaochun Ma; Xu Li
Journal:  BMC Anesthesiol       Date:  2022-01-21       Impact factor: 2.217

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.